Congratulations to the following faculty members for receiving these sponsored research awards:
Sponsored Research
Senthil Selvaraj of Cardiology has received an award from the Medical College of Virginia Foundation for a project entitled "Diversifying Recruitment to Improve Generalizability of Therapeutic Ketosis Strategies in Heart Failure." Total funding will be $240,000.
Neesha Namasingh (Mentor: Matthew Crowley) of Endocrinology has received an award from the Endocrine Fellows Foundation for a project entitled "Impact of endocrine disrupting chemicals on gestational glycemia and peripartum weight retention." Total funding will be $10,000.
Katherine Garman of Gastroenterology has received a sub-award (1RC2-TR005123-01A1) through the University of North Carolina - Chapel Hill for a project entitled "Porcine Related apprOach to Multidisciplinary cOllaborative Translational ModEl Research (PROMOTER)." Total funding will be $11,173.
Charity Oyedeji of Hematology has received an award from the Medical College of Virginia Foundation for a project entitled "Randomized Control Trial of The SickleFit Exercise Program in Older Adults with Sickle Cell Disease." Total funding will be $240,000.
Jacqueline Hodges of Infectious Diseases has received a sub-award () through the Durham Technical Community College for a project entitled "Project MAPS (Mobile Addiction Treatment and Primary Care Services)." Total funding will be $58,735.
Laura Svetkey of Nephrology has received an award (1K12-TR005435-01) from the National Institutes of Health for a project entitled "2/3 CTSA K12 Program at Duke University." Total funding will be $7,888,905.
Alexandra Thomas of Oncology has received a sub-award () through the Wake Forest University Health Sciences for a project entitled "Predicting cancer treatment-related cardiotoxicity by imaging cardiac mechanical stiffness." Total funding will be $6,409.
Robert Tighe of Pulmonary has received an award from the Duke Endowment for a project entitled "Combatting the Health Impacts of Climate Change in the Carolinas." Total funding will be $4,500,000.
Industry Sponsored Clinical Trials
James Daubert of Cardiology has received an award from Cardurion Pharmaceuticals, Inc. for a project entitled "A Phase 2 Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study To Evaluate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia." Total funding will be $119,754.
Daniel Friedman of Cardiology has received an award from Medtronic, Inc. for a project entitled "TRANSvENous Diaphragmatic Pacing for Heart Failure:(TRANSCEND-HF)." Total funding will be $49,328.
Marat Fudim of Cardiology has received an award from Bristol-Myers Squibb Company for a project entitled "A Phase 2A, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986435/MYK-224 in Participants with Heart Failure with Preserved Ejection Fraction HFpEF." Total funding will be $175,393.
Donald Hegland of Cardiology has received an award from Medtronic, Inc. for a project entitled "FY26 - Clinical Cardiac Electrophysiology Fellowship Grant." Total funding will be $20,000.
Michel Khouri of Cardiology has received an award from Eidos Therapeutics for a project entitled "A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy." Total funding will be $324,004.
Sudarshan Rajagopal of Cardiology has received an award from United Therapeutics Corporation for a project entitled "X-TRIPP UT PH ILD and XeMRI MutiSite study Pro00118547 Assessing Acute Pharmacodynamics and Long-Term Response to Inhaled Prostacyclin with Hyperpolarized 129Xe MRI in patients with PH-ILD." Total funding will be $561,882.
Nishant Shah of Cardiology has received an award from Corcept Therapeutics, Inc. for a project entitled "Study of the Prevalence of Endogenous Hypercortisolism in Patients with Resistant Hypertension (MOMENTUM)." Total funding will be $118,125.
Harry Erba of Cell Therapy has received an award from Kura Oncology, Inc. for a project entitled "Studies to Assess Ziftomenib in Combination with Ven+Aza or 7+3 in Patients with Untreated NPM1-m or KMT2A-r AML." Total funding will be $1,541,312.
Cristina Gasparetto of Cell Therapy has received a sub-award () through National Marrow Donor Program for a project entitled "Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation MajesTEC-4." Total funding will be $497,847.
Mitchell Horwitz of Cell Therapy has received an award from Deciphera Pharmaceuticals, LLC for a project entitled "Deciphera DCC-3014-02-001: A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy." Total funding will be $346,613.
Yubin Kang of Cell Therapy has received an award from Regeneron Pharmaceuticals, Inc. for a project entitled "PHASE 1/2 STUDY OF LINVOSELTAMAB (ANTI-BCMA X ANTI-CD3 BISPECIFIC ANTIBODY) IN PREVIOUSLY UNTREATED PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA." Total funding will be $964,595.
Jonathan Campbell of Endocrinology has received an award from Eli Lilly and Company for a project entitled "Eli Lilly #2 - Metabolic effects of glucagon pharmacology." Total funding will be $727,848.
Matthew Kappus of Gastroenterology has received an award from COUR Pharmaceuticals Development Company for a project entitled "P2b Primary Biliary Cholangitis trial CNP-104-CL-202." Total funding will be $310,525.
Thomas Ortel of Hematology has received an award from Diagnostica Stago, Inc. for a project entitled "sThemO 301 Analyzer Part B." Total funding will be $50,947.
Thomas Ortel of Hematology has received an award from US Thrombotic Microangiopathy Alliance for a project entitled "USTMA P200 Registry Agreement." Total funding will be $17,500.
John Perfect of Infectious Diseases has received an award from Basilea Pharmaceutica International Ltd, Allschwil for a project entitled "Efficacy, Pharmacokinetics, and Pharmacodynamics of APX2039 in a Rabbit Model of Cryptococcal Meningitis." Total funding will be $446,748.
John Perfect of Infectious Diseases has received an award from Novartis Institutes for BioMedical Research for a project entitled "Development of genetic tools in Cryptococcus neoformans to chemically validate the GPI-AP (Glycosylphosphatidylinositol-anchored proteins) biosynthetic pathway." Total funding will be $345,549.
John Perfect of Infectious Diseases has received an award from Basilea Pharmaceutica for a project entitled "BAL2039 Susceptibility Testing of Cryptococcus neoformans." Total funding will be $27,000.
Laura Alder of Oncology has received an award from Henlius USA Inc. for a project entitled "An Open-label, Multi-center, Global Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Subjects with Advanced Non-small Cell Lung Cancer (NSCLC)." Total funding will be $322,119.
Andrew Armstrong of Oncology has received an award from Fibrogen, Inc. for a project entitled "A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients with Metastatic Castration-Resistant Prostate Cancer." Total funding will be $411,526.
Nicholas DeVito of Oncology has received an award from GlaxoSmithKline for a project entitled "A Phase1b/2, multicenter, randomized, open-label study to evaluate the efficacy and safety of GSK5764227 alone and in combination in participants with previously treated advanced unresectable or metastatic gastrointestinal solid tumors." Total funding will be $4,493,198.
Daniel George of Oncology has received an award from Astellas Pharma Global Development, Inc for a project entitled "Retrospective study of 1L la/mUC patients." Total funding will be $796,666.
Niharika Mettu of Oncology has received an award from MOMA Therapeutics, Inc. for a project entitled "A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants with Advanced or Metastatic Solid Tumors." Total funding will be $347,295.
Eziafa Oduah of Oncology has received an award from Janssen Research & Development, LLC for a project entitled "A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-Line Treatment, for Common EGFR-Mutated." Total funding will be $262,078.
Aman Opneja of Oncology has received an award from Lilly USA, LLC for a project entitled "A Dose Escalation and Dose Optimization Phase 1a/1b Study to Evaluate Safety, Tolerability and Dosimetry of Radioligand Therapy with LY4337713 in Adults with FAP-Positive Solid Tumors (FiREBOLT)." Total funding will be $801,560.
Alexandra Thomas of Oncology has received an award from Quantum Leap Healthcare Collaborative for a project entitled "I-SPY 2 Trial: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2." Total funding will be $1.
Lake Morrison of Pulmonary has received an award from Mediar Therapeutics, Inc. for a project entitled "MTX-463-I201 Mediar Study -A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)." Total funding will be $167,524.
Amanda Eudy of Rheumatology has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "LILAC - Anifrolumab in DLR." Total funding will be $305,619.